| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |